Vicarious Surgical Unveils Presentation on Transforming Robotic Surgery with Advanced Technology and Market Opportunities

Reuters

2025/09/04

Vicarious Surgical Unveils Presentation on Transforming Robotic Surgery with Advanced Technology and Market Opportunities

Vicarious Surgical Inc. has presented details about its advanced surgical robot, which is specifically designed for general surgery. The robot leverages proprietary decoupled actuators aimed at enhancing ease of use, clinical outcomes, and economic efficiency across high-volume surgical procedures. The company has established fortified manufacturing capabilities and an integrated supply chain, ready for scaling operations. Vicarious Surgical is supported by leading partners, including HCA and major investors such as Khosla Ventures and Bill Gates. The presentation highlights a significant market opportunity, with a potential value of $150 billion and 45 million addressable abdominal robotic procedures worldwide per year. Currently, 96% of these procedures are conducted manually, with robotic adoption hindered by factors such as high costs, limited access, and difficulties in use and training. You can access the full presentation through the link below.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vicarious Surgical Inc. published the original content used to generate this news brief on September 04, 2025, and is solely responsible for the information contained therein.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2564434305"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2564434305\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2564434305?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-04 23:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2564434305","market":"nz","top_or_hot":-1,"title":"Vicarious Surgical Unveils Presentation on Transforming Robotic Surgery with Advanced Technology and Market Opportunities","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Vicarious Surgical Unveils Presentation on Transforming Robotic Surgery with Advanced Technology and Market Opportunities\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/RBOT\">Vicarious Surgical Inc.</a> has presented details about its advanced surgical robot, which is specifically designed for general surgery. The robot leverages proprietary decoupled actuators aimed at enhancing ease of use, clinical outcomes, and economic efficiency across high-volume surgical procedures. The company has established fortified manufacturing capabilities and an integrated supply chain, ready for scaling operations. Vicarious Surgical is supported by leading partners, including HCA and major investors such as <a href=\"https://laohu8.com/S/KVSC\">Khosla Ventures</a> and Bill Gates. The presentation highlights a significant market opportunity, with a potential value of $150 billion and 45 million addressable abdominal robotic procedures worldwide per year. Currently, 96% of these procedures are conducted manually, with robotic adoption hindered by factors such as high costs, limited access, and difficulties in use and training. You can access the full presentation through the link below.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vicarious Surgical Inc. published the original content used to generate this news brief on September 04, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vicarious Surgical Unveils Presentation on Transforming Robotic Surgery with Advanced Technology and Market Opportunities</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVicarious Surgical Unveils Presentation on Transforming Robotic Surgery with Advanced Technology and Market Opportunities\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-09-04 23:29</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Vicarious Surgical Unveils Presentation on Transforming Robotic Surgery with Advanced Technology and Market Opportunities\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/RBOT\">Vicarious Surgical Inc.</a> has presented details about its advanced surgical robot, which is specifically designed for general surgery. The robot leverages proprietary decoupled actuators aimed at enhancing ease of use, clinical outcomes, and economic efficiency across high-volume surgical procedures. The company has established fortified manufacturing capabilities and an integrated supply chain, ready for scaling operations. Vicarious Surgical is supported by leading partners, including HCA and major investors such as <a href=\"https://laohu8.com/S/KVSC\">Khosla Ventures</a> and Bill Gates. The presentation highlights a significant market opportunity, with a potential value of $150 billion and 45 million addressable abdominal robotic procedures worldwide per year. Currently, 96% of these procedures are conducted manually, with robotic adoption hindered by factors such as high costs, limited access, and difficulties in use and training. You can access the full presentation through the link below.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vicarious Surgical Inc. published the original content used to generate this news brief on September 04, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RBOT","symbol_name":"Vicarious Surgical Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250904:nNDL38y548:1","article_id":"2564434305","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2564434305","pubTimestamp":1756999781,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Vicarious Surgical Inc. has presented details about its advanced surgical robot, which is specifically designed for general surgery. The robot leverages proprietary decoupled actuators aimed at enhancing ease of use, clinical outcomes, and economic efficiency across high-volume surgical procedures. The company has established fortified manufacturing capabilities and an integrated supply chain, ready for scaling operations. Vicarious Surgical is supported by leading partners, including HCA and major investors such as Khosla Ventures and Bill Gates. The presentation highlights a significant market opportunity, with a potential value of $150 billion and 45 million addressable abdominal robotic procedures worldwide per year. Currently, 96% of these procedures are conducted manually, with robotic adoption hindered by factors such as high costs, limited access, and difficulties in use and training. You can access the full presentation through the link below.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"RBOT":"Vicarious Surgical Inc.","BK4082":"医疗保健设备"},"translate_title":"Vicarious Surgical推出关于利用先进技术和市场机会改变机器人手术的演讲","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RBOT":0.9},"content_text":"Vicarious Surgical Unveils Presentation on Transforming Robotic Surgery with Advanced Technology and Market Opportunities\n    \n\nVicarious Surgical Inc. has presented details about its advanced surgical robot, which is specifically designed for general surgery. The robot leverages proprietary decoupled actuators aimed at enhancing ease of use, clinical outcomes, and economic efficiency across high-volume surgical procedures. The company has established fortified manufacturing capabilities and an integrated supply chain, ready for scaling operations. Vicarious Surgical is supported by leading partners, including HCA and major investors such as Khosla Ventures and Bill Gates. The presentation highlights a significant market opportunity, with a potential value of $150 billion and 45 million addressable abdominal robotic procedures worldwide per year. Currently, 96% of these procedures are conducted manually, with robotic adoption hindered by factors such as high costs, limited access, and difficulties in use and training. You can access the full presentation through the link below.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vicarious Surgical Inc. published the original content used to generate this news brief on September 04, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}